VR Adviser’s Myovant Sciences Ltd. MYOV Stock Holding History

VR Adviser’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-845,000	Closed	-$17.4M	–	28
2020 Q2	$17.4M	Buy	+845,000	New	+$11.5M	4.17%	8

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VR Adviser's MYOV Position: Q3 2020 in Review

VR Adviser sold out of Myovant Sciences Ltd. (MYOV) in Q3 2020, closing a stake of 845,000 shares — an estimated $17.4M sold.

VR Adviser first reported a position in MYOV in Q2 2020 and held it in 1 quarter. The position peaked at $17.4M in Q2 2020. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

VR Adviser reported no remaining Myovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
VR Adviser sold 845,000 Myovant Sciences Ltd. shares in Q3 2020, an estimated $17.4M.
VR Adviser first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 1 quarter.
VR Adviser's Myovant Sciences Ltd. position peaked at $17.4M in Q2 2020.
102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on VR Adviser's 13F filing for Q3 2020, filed 16 Nov 2020.